Terms: = Sarcomas AND LYL1, P12980, 4066, ENSG00000104903
6 results:
1. Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini E; Reichardt P; Hall KS; Bertulli R; Bielack SS; Comandone A; Egerer G; Hansmeier A; Kevric M; Carretta E; Hansson L; Jebsen N; Eriksson M; Bruland ØS; Donati DM; Ibrahim T; Smeland S; Ferrari S
Cancer; 2023 Nov; 129(22):3564-3573. PubMed ID: 37530385
[TBL] [Abstract] [Full Text] [Related]
2. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
[TBL] [Abstract] [Full Text] [Related]
3. Can 18F-FDG PET/CT diagnose malignant change in benign chondroid tumors?
Purandare NC; Puranik A; Shah S; Agrawal A; Puri A; Gulia A; Nayak P; Rekhi B; Rangarajan V
Nucl Med Commun; 2019 Jun; 40(6):645-651. PubMed ID: 30921251
[TBL] [Abstract] [Full Text] [Related]
4. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.
George S; Blay JY; Casali PG; Le Cesne A; Stephenson P; Deprimo SE; Harmon CS; Law CN; Morgan JA; Ray-Coquard I; Tassell V; Cohen DP; Demetri GD
Eur J Cancer; 2009 Jul; 45(11):1959-68. PubMed ID: 19282169
[TBL] [Abstract] [Full Text] [Related]
5. High complication rate of reconstruction using Ilizarov bone transport method in patients with bone sarcomas.
Ozaki T; Nakatsuka Y; Kunisada T; Kawai A; Dan'ura T; Naito N; Inoue H
Arch Orthop Trauma Surg; 1998; 118(3):136-9. PubMed ID: 9932187
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.
Würl P; Taubert H; Meye A; Dansranjavin T; Weber E; Günther D; Berger D; Schmidt H; Dralle H; Rath FW
Virchows Arch; 1997 Mar; 430(3):221-5. PubMed ID: 9099979
[TBL] [Abstract] [Full Text] [Related]